SOURCE: World Street Fundamentals

June 27, 2011 09:13 ET

Equity Research on Akorn, Inc. and Novartis AG -- Staying Strong and Healthy

HONG KONG--(Marketwire - Jun 27, 2011) - Today, www.WorldStreetFundamentals.com released its industry report highlighting Akorn, Inc. (NASDAQ: AKRX) and Novartis AG (NYSE: NVS). Full fundamental and technical analysis is available at www.WorldStreetFundamentals.com/Reports.php.

While it is thought that the recent health care reform legislation will negatively affect industry profitability over the next few years, it has seen eventual benefits accruing from significant expansion of the market. Firms with well-defined growth prospects and generous dividend yields should sustain as they should perform relatively well over the coming quarters. Pharmaceuticals should remain one of the widest-margin industries, with prospects enhanced by demographic growth in the elderly and new drugs stemming from discoveries in genomics and biotechnology. The global medical industry is one of the world's fastest growing, absorbing over 10% of the Gross Domestic Product of most developed countries.

World Street Fundamentals has highlighted Akorn, Inc. as it manufactures and markets a range of diagnostic and therapeutic ophthalmic pharmaceuticals, as well as niche hospital drugs and injectable pharmaceuticals. In addition, the Company has marketed and distributed vaccines purchased from outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. The entire report on Akorn, Inc. (NASDAQ: AKRX) is available here: www.WorldStreetFundamentals.com/ViewFullReport.245.php.

World Street has emphasized Novartis AG as a provider of healthcare solutions. The Company's portfolio includes medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. The Company operates in four divisions: pharmaceuticals, vaccines and diagnostics, sandoz, and consumer health. On August 25, 2010, Novartis completed the acquisition of a further 52% interest in Alcon, Inc. On April 8, 2011, the Company completed the merger of Alcon, Inc. The entire report on Novartis AG (NYSE: NVS) is available here: www.WorldStreetFundamentals.com/ViewFullReport.138.php.

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets. Covering the top performers in the hottest sectors and providing clarity to investors around the world.

Contact Information